Human acellular vessel (Humacyte)

N/A

Report date: 2024/12/31 11:07:02
First In Class

Base Information

Drug NameHuman acellular vessel (Humacyte)
Drug Alias NameHAVG graft implantationHuman acellular vascular graft (Humacyte)Acellular Tissue Engineered Vessel (Humacyte)HUMACYLHUMAGRAFT +[9] 
ClassificationBiologics
Mechanisms of ActionTissue replacements
TargetsUpdating
Therapy Area/IndicationsWounds and InjuriesVascular System InjuriesPeripheral Arterial Disease +[7] 
Global Approved IndicationsVascular System Injuries
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2024/12/19
Country/TerritoryUnited StatesPolandPortugal +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesHumacyte Inc
China Registration ClassN/A

Develop Information

Active CompaniesHumacyte Inc
Inactive CompaniesN/A
Active IndicationsVascular System InjuriesPeripheral Arterial DiseaseVascular Diseases +[6] 
Inactive IndicationsWounds and Injuries

Other Information

ATC CodeN/A
Related LinksN/A